TY  - JOUR
PY  - 2019//
TI  - Feasibility and safety of Robot Suit HAL treatment for adolescents and adults with cerebral palsy
JO  - Journal of clinical neuroscience
A1  - Ueno, Tomoyuki
A1  - Watanabe, Hiroki
A1  - Kawamoto, Hiroaki
A1  - Shimizu, Yukiyo
A1  - Endo, Ayumu
A1  - Shimizu, Tomoe
A1  - Ishikawa, Kimihisa
A1  - Kadone, Hideki
A1  - Ohto, Tatsuyuki
A1  - Kamada, Hiroshi
A1  - Marushima, Aiki
A1  - Hada, Yasushi
A1  - Muroi, Ai
A1  - Sankai, Yoshiyuki
A1  - Ishikawa, Eiichi
A1  - Matsumura, Akira
A1  - Yamazaki, Masashi
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - To investigate whether Robot Suit HAL treatment (HAL-T) is safe and feasible for gait disorders in adolescents and adults with cerebral palsy (CP). We tested HAL-T in adolescents and adults with bilateral spastic CP (four men, four women; mean age: 18.2 years). Three participants were classified as level III under the Gross Motor Function Classification System (GMFCS), and five were classified as level IV. The participants underwent HAL-T twice per week for 4 weeks. The outcome measures, which were assessed before and after HAL-T, included comfortable gait speed (CGS), step length (SL), cadence, and GMFCS level. Adverse events were noted. All participants completed the HAL-T sessions despite some mild adverse events occurring. The mean increases in CGS, SL, and cadence were 0.19 ± 0.14 m/s (p = 0.006), 0.09 ± 0.08 m (p = 0.020), and 18.0 ± 15.9 steps/min (p = 0.015), respectively. HAL-T is safe and feasible for gait disorders in patients with CP. HAL-T can significantly improve CGS, SL, and cadence and may be effective for improving walking ability in adolescents and adults with CP.<br><br>Copyright © 2019 Elsevier Ltd. All rights reserved.<p />  <p>Language: en</p>
LA  - en
SN  - 0967-5868
UR  - http://dx.doi.org/10.1016/j.jocn.2019.07.026
ID  - ref1
ER  -